Edwards Lifesciences Corp (EW.N)
15 Aug 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|65||2000||Chairman of the Board, Chief Executive Officer|
|51||2014||Chief Financial Officer, Corporate Vice President|
|60||2017||Corporate Vice President, EMEA (Europe, Middle East and Africa)|
|56||2007||Corporate Vice President - Heart Valve Therapy|
|51||2015||Corporate Vice President- Critical Care|
- BRIEF-Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards Sapien 3 Valve
- BRIEF-Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement
- BRIEF-Edwards Lifesciences Says Entered Into Credit Agreement To Establish Multi-Currency Unsecured Revolving Credit Facility - SEC Filing
- BRIEF-Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy
- Edward Lifesciences' heart valve sales in Europe disappoint, shares fall